|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-4-15
|
|
pubmed:abstractText |
To assess the ability of 59 clinical microbiology laboratories distributed throughout Italy to correctly identify and detect reduced susceptibility to glycopeptides in staphylococci and VanA-, VanB- or VanC-mediated glycopeptide resistance in enterococci.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1198-743X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
101-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11952723-Anti-Bacterial Agents,
pubmed-meshheading:11952723-Diffusion,
pubmed-meshheading:11952723-Drug Resistance, Bacterial,
pubmed-meshheading:11952723-Enterococcus,
pubmed-meshheading:11952723-Hospitals,
pubmed-meshheading:11952723-Italy,
pubmed-meshheading:11952723-Microbial Sensitivity Tests,
pubmed-meshheading:11952723-Quality Control,
pubmed-meshheading:11952723-Sensitivity and Specificity,
pubmed-meshheading:11952723-Staphylococcus,
pubmed-meshheading:11952723-Teicoplanin,
pubmed-meshheading:11952723-Vancomycin,
pubmed-meshheading:11952723-Vancomycin Resistance
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
|
|
pubmed:affiliation |
Focus Technologies Inc., Hilversum, The Netherlands. mjones@focusanswers.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
